Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial
Padmanee Sharma(The University of Texas MD Anderson Cancer Center), Russell K. Pachynski(Washington University in St. Louis), Vivek Narayan(University of Pennsylvania), Aude Fléchon(Centre Léon Bérard), Gwénaëlle Gravis(Aix-Marseille Université), Matthew D. Galsky(Icahn School of Medicine at Mount Sinai), Hakim Mahammedi(Centre Jean Perrin), Akash Patnaik(University of Chicago), Sumit K. Subudhi(The University of Texas MD Anderson Cancer Center), Marika Ciprotti(Bristol-Myers Squibb (United Kingdom)), Burçin Şimşek(Bristol-Myers Squibb (United States)), Abdel Saci(Bristol-Myers Squibb (United States)), Yanhua Hu(Bristol-Myers Squibb (United States)), G. Celine Han(Bristol-Myers Squibb (United States)), Karim Fizazi(Université Paris-Saclay)
Cited by 392
Abstract
Related Papers
No related papers found
Powered by citation graph analysis